N/A N=75 Randomized Screening

Warning Signs of Squamous Cell Carcinoma and Prevention of SCC by at Risk Organ Transplant Recipients

Squamous Cell Carcinoma

Bottom Line

View on ClinicalTrials.gov: NCT01127737 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2011

Primary outcome: Primary: Number of Control and Intervention Participants on Skin Self-examination Performance at Follow-up 1 Month After Intervention — 34; 8 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Educational Intervention (Behavioral); Placebo (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Northwestern University
Primary completion: Apr 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Control and Intervention Participants on Skin Self-examination Performance at Follow-up 1 Month After Intervention	34; 8	—

Summary

Using focus group and cognitive interviews with organ transplant recipients, the investigators developed interactive workbooks: a) prevention by sun protection b) early detection by skin self-examination (SSE). The investigators hypothesis is if the patient learns by acquiring skills in a favorable environment, then the patient may reduce their anxiety, enhance self-efficacy and perform self-management by SSE and sun protection. The investigators also evaluate existing internet sources of primary and secondary prevention of skin cancer for organ transplant recipients.

Eligibility Criteria

Inclusion Criteria

People with a history of solid organ transplantation within the last 2 years
Speaks English
Can see to do SSE, capable of seeing to read a newspaper
Stable health, patients report a general state of well being

Exclusion Criteria

Unable to speak English
Insufficient vision to see their own skin as determined by their ability to read a newspaper
Comorbid debilitating disease
Dementia or insufficient cognitive skills to follow instructions provided at a sixth grade language level.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01127737). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.